Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance

scientific article published on 21 August 2015

Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1005953492
P356DOI10.1007/S40618-015-0372-X
P698PubMed publication ID26294351

P2093author name stringC Giordano
A Ciresi
M C Amato
E Vigneri
R Vesco
P2860cites workExecutive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)Q27860959
Standards of medical care in diabetes--2014Q28304435
Banting lecture 1988. Role of insulin resistance in human diseaseQ29547283
Visceral adiposity index: an indicator of adipose tissue dysfunctionQ33563343
Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implicationsQ33569169
Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk.Q33751624
The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitusQ33853759
Disposition index, glucose effectiveness, and conversion to type 2 diabetes: the Insulin Resistance Atherosclerosis Study (IRAS)Q34084640
Glucose clamp technique: a method for quantifying insulin secretion and resistanceQ34191986
Clinical assessment of body hair growth in womenQ34252149
Insulin Secretion in Response to Glycemic Stimulus: Relation of Delayed Initial Release to Carbohydrate intolerance in Mild Diabetes Mellitus*Q34267205
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).Q34285382
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitusQ34679108
Clinical risk factors, DNA variants, and the development of type 2 diabetesQ34884389
Defining insulin resistance from hyperinsulinemic-euglycemic clampsQ36047260
OGTT-derived measures of insulin sensitivity are confounded by factors other than insulin sensitivity itselfQ36157911
Molecular mechanisms of insulin resistance in polycystic ovary syndromeQ36504052
Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucoseQ37006231
Glucose ingestion in dogs alters the hepatic extraction of insulin. In vivo evidence for a relationship between biologic action and extraction of insulinQ37008182
Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levelsQ37067149
Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular diseaseQ37742798
Glucose intolerance states in women with the polycystic ovary syndromeQ38150697
C-Peptide as a Measure of the Secretion and Hepatic Extraction of Insulin: Pitfalls and LimitationsQ40177948
The Metabolism of Proinsulin and Insulin by the LiverQ40371390
The Determinants of Insulin Extraction in the Isolated Perfused Rat LiverQ41561160
Kinetics of insulin receptor internalization and recycling in adipocytes. Shunting of receptors to a degradative pathway by inhibitors of recycling.Q41917179
Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signalingQ42472147
Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndromeQ42497234
Insulin and C-peptide secretion in non-obese patients with polycystic ovarian diseaseQ42497497
Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients.Q42507682
Variants at DGKB/TMEM195, ADRA2A, GLIS3 and C2CD4B loci are associated with reduced glucose-stimulated beta cell function in middle-aged Danish peopleQ43085753
A critical evaluation of simple methods for the estimation of free testosterone in serumQ49081910
Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clampQ50880365
Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels.Q51343168
Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators.Q51562946
Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.Q51598262
Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean-Hispanic women.Q51598723
Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome.Q53634712
Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndromeQ60717465
The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic riskQ63256614
Insulin resistance and polycystic ovary syndromeQ63256652
Effect of infusion of insulin into portal vein on hepatic extraction of insulin in anesthetized dogsQ66929267
Insulin and C-peptide levels in obese patients with polycystic ovariesQ71439126
Impaired in vivo insulin clearance in patients with severe target-cell resistance to insulinQ71470113
Ovarian volume in gynecologically healthy women using no contraception, or using IUD or oral contraceptionQ73827071
P433issue12
P921main subjectpolycystic ovary syndromeQ500816
polycystic ovaryQ5547896
P304page(s)1319-1326
P577publication date2015-08-21
P1433published inJournal of Endocrinological InvestigationQ15766847
P1476titleHyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance
P478volume38

Reverse relations

cites work (P2860)
Q41116375Association of polycystic ovary syndrome with metabolic syndrome and gestational diabetes: Aggravated complication of pregnancy
Q47977267Clinical significance of ADAMTS1, ADAMTS5, ADAMTS9 aggrecanases and IL-17A, IL-23, IL-33 cytokines in polycystic ovary syndrome
Q38937980Effect of metformin and oral contraceptives on polycystic ovary syndrome and IVF cycles
Q53122744Evidence for decreased expression of APPL1 associated with reduced insulin and adiponectin receptors expression in PCOS patients.
Q41111951Evolution of metabolic alterations 5 Years after early puberty in a cohort of girls predisposed to polycystic ovary syndrome
Q33762580Frequency of nodular goiter and autoimmune thyroid disease and association of these disorders with insulin resistance in polycystic ovary syndrome
Q51277229Gly972Arg of IRS-1 and Lys121Gln of PC-1 polymorphisms act in opposite way in polycystic ovary syndrome.
Q45974242Hyperandrogenemia Induced by Letrozole Treatment of Pubertal Female Mice Results in Hyperinsulinemia Prior to Weight Gain and Insulin Resistance.
Q36228285Menstrual Cycle Irregularity and Metabolic Disorders: A Population-Based Prospective Study
Q58793563Morning blood pressure surge and its relation to insulin resistance in patients of reproductive age with polycystic ovary syndrome
Q37549090New markers of insulin resistance in polycystic ovary syndrome
Q64933869Nutrition and Female Fertility: An Interdependent Correlation.
Q87663139Plasma total oxidant and antioxidant status after oral glucose tolerance and mixed meal tests in patients with polycystic ovary syndrome
Q53146967The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes.
Q53761370Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.

Search more.